Skip to main content
Glycorex Transplantation AB logo

Glycorex Transplantation AB — Investor Relations & Filings

Ticker · GTAB ISIN · SE0000524530 LEI · 549300BFHBYZ3X96EP25 NGM Manufacturing
Open in API
Filings indexed 97 across all filing types
Latest filing 2021-06-23 Regulatory Filings
Country SE Sweden
Listing NGM GTAB

About Glycorex Transplantation AB

https://glycorex.com/

Glycorex Transplantation AB is a medical technology company that has developed a proprietary technology platform for the specific removal of antibodies from blood. The technology is based on biologically active carbohydrates for extracorporeal blood treatment. Its flagship product, Glycosorb® ABO, is a single-use medical device that enables organ transplantation across the blood group barrier, primarily for kidney, liver, heart, and stem cell transplants. Used clinically since 2001, the product has facilitated over 6,000 ABO-incompatible transplants with documented long-term results comparable to blood group compatible procedures. The company is leveraging its core technology to expand into new applications, including a product for creating universal blood plasma for transfusions and developing novel treatments for autoimmune diseases, with an initial focus on rheumatoid arthritis.

Recent filings

Filing Released Lang Actions
Glycorex Transplantation AB (GTAB B): Uppdatering kring UBP-produkten
Regulatory Filings Classification · 95% confidence The document is a corporate press release from Glycorex Transplantation AB providing an update on the clinical evaluation and progress of their UBP product. It details recent presentations at medical congresses, ongoing studies in various countries, and future development plans. It concludes with a standard regulatory disclosure statement required by the EU Market Abuse Regulation, indicating it is a general corporate announcement. It does not fit into specific categories like financial reports, dividend notices, or board changes, making 'Regulatory Filings' (RNS) the most appropriate classification for this type of corporate update.
2021-06-23 Swedish
Glycorex Transplantation AB (GTAB B): Pontus Nobréus lämnar rollen som verkställande direktör
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the departure of the CEO (Pontus Nobréus) and the appointment of an interim CEO (Johan Nilsson). This falls directly under the category of changes in senior management.
2021-06-15 Swedish
Glycorex Transplantation AB (GTAB B): Årsstämman 8 juni 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement regarding the results of the Annual General Meeting (Årsstämma) held by Glycorex Transplantation AB on June 8, 2021. It summarizes the decisions made during the meeting, such as the approval of financial statements, election of board members, and authorization for new share issues. Since it reports the official outcomes and voting results of the general meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-06-08 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport' (Interim Report) for the period January-March 2021. It contains comprehensive financial statements, including a balance sheet/income statement table, management commentary (VD-kommentar), and detailed business updates. It is clearly a quarterly financial report, not an announcement of a report or a summary, and it contains substantive financial data. Q1 2021
2021-05-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Interim report' and covers the period 'January-March 2021'. It contains detailed financial statements, including a balance sheet/income statement table, CEO comments, and operational updates. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2021
2021-05-19 English
Glycorex Transplantation (GTAB B): Kallelse till årsstämma 8 juni 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (Årsstämma) for Glycorex Transplantation AB. It contains the agenda, voting procedures, proposals for board elections, remuneration guidelines, and instructions for shareholders. This is a classic proxy statement/notice of meeting document sent to shareholders to provide information and request votes for the upcoming AGM.
2021-05-11 Swedish

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.